Construction of Drug Network Based on Side Effects and Its Application for Drug Repositioning

Open Access

Peer-reviewed

Research Article

Hao Ye,

Affiliation R&D Information, AstraZeneca, Shanghai, China
⨯
Qi Liu,

Affiliation School of Life Sciences and Technology, Tongji University, Shanghai, China
⨯
Jia Wei

* E-mail: jenny.wei@astrazeneca.com

Affiliation R&D Information, AstraZeneca, Shanghai, China
⨯

Reader Comments (0)

Adverse reactions
Is the Subject Area "Adverse reactions" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Depression
Is the Subject Area "Depression" applicable to this article?

Thanks for your feedback.
Drug information
Is the Subject Area "Drug information" applicable to this article?

Thanks for your feedback.
Rheumatoid arthritis
Is the Subject Area "Rheumatoid arthritis" applicable to this article?

Thanks for your feedback.
Prostaglandins
Is the Subject Area "Prostaglandins" applicable to this article?

Thanks for your feedback.
Antidepressant drug therapy
Is the Subject Area "Antidepressant drug therapy" applicable to this article?

Thanks for your feedback.
Levodopa
Is the Subject Area "Levodopa" applicable to this article?

Thanks for your feedback.